The pharmaceutical sales in Belgium exhibited a fairly stable trend from 2013 to 2014, maintaining at €5.95 billion. From 2015 onwards, there has been a consistent upward trend, reaching €9.53 billion in 2023. Notably, from 2021 to 2023, the market experienced significant growth, with year-on-year increases of 11.86% and 5.76% respectively. The Compound Annual Growth Rate (CAGR) over the last five years, culminating in 2023, stands at 7.35%. Looking forward, the forecasted CAGR from 2024 to 2028 is estimated at 4.65%, with a projected sales value of €12.79 billion by 2028, indicating a growth rate of 25.5% over this period.
Future trends to watch for include the impact of new pharmaceutical innovations, policy regulations related to healthcare, and the evolving dynamics of market demand post-COVID-19. Additionally, the digital transformation in healthcare and the increasing focus on personalized medicine are likely to shape the pharmaceutical market landscape in Belgium in the coming years.
